id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
dpc-5570	Artosi, Fabio; Lanna, Caterina; Gaeta Shumak, Ruslana; Borselli, Cristiana; Costanza, Gaetana; Rivieccio, Antonia; Orsini, Diego; Lambiase, Sara; Diluvio, Laura; Bianchi, Luca; Campione, Elena	Tildrakizumab as a Potential Option for Early Psoriatic Arthritis in Patients with Metabolic Comorbidities and Psoriasis: a Case Series	2025	8	.pdf	application/pdf	5033	333	64	In order to explain the effectiveness of anti-IL-23 drugs on the arthritic process, some authors have suggested that elevated levels of IL-23 in the synovial fluid of PsA patients may play a key role in the pathogenesis[2, 9–11]. Currently available data support a clear association between nail psoriasis and PsA, with further evidence sug- gesting that improvement in nail disease correlates with im- provement in joint involvement[13]. Dermatologists must also consider the issue of metabolic cardiovascular risk in PsA patients, as shown by our data as well [21].	cache/dpc-5570.pdf	txt/dpc-5570.txt